Reducing Sedentary Time in Patients With Heart Failure



Status:Active, not recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:65 - 100
Updated:1/19/2019
Start Date:September 2016
End Date:May 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
To determine the change in sedentary time and number of steps/day for older patients with
heart failure at risk for mobility disability who receive a program to decrease sedentary
behavior versus a standard program to increase exercise.


Inclusion Criteria:

- NYHA II-IV,

- Age ≥ 65,

- SPPB score of > 4 and ≤ 10 of 12,

- and deemed (by 1° cardiologist) to be at maximal tolerated dose of heart failure
medication (ACE-inhibitor (ACE-I)/angiotensin receptor blocker and beta blocker
(BB) for patients with HF with reduced ejection fraction (HFrEF), and

- blood pressure controlled for HF with preserved ejection fraction (HFpEF)
according to the American Heart Failure Association HF guidelines.

Exclusion Criteria:

- Patients requiring medication titration such as ACE-I or BB, (will return to their
cardiologist and be eligible after 3 months of stable medication.)

- Oxygen dependent lung disease,

- Orthopedic or neurologic disease that severely limits mobility,

- Active cancer diagnosis except non-melanoma skin cancer,

- Geriatric Depression Scale (GDS) score of ≥ 9 ,

- Limited life-expectancy of <6 months,

- Known dementia or disease that effects ability to learn/follow directions, or

- Failed MiniCog test.
We found this trial at
1
site
University of Colorado University
12605 East 16th Avenue
Aurora, Colorado 80045
Principal Investigator: Rebecca Boxer, MS,MD
Phone: 720-848-7561
?
mi
from
Aurora, CO
Click here to add this to my saved trials